Clinical Trial Update: Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing KRd (carfilzomib, lenalidomide, dexamethasone) versus VRd (bortezomib, lenalidomide, dexamethasone) in newly diagnosed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (dexamethasone) (dexamethasone)
• Kyprolis (carfilzomib) (carfilzomib)
• Revlimid (lenalidomide) (lenalidomide)
• Velcade (bortezomib) (bortezomib)

Snippet

Sponsor: University of Chicago | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING